SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001564590-17-007755
Filing Date
2017-04-28
Accepted
2017-04-28 16:01:13
Documents
4
Period of Report
2017-06-15
Effectiveness Date
2017-04-28

Document Format Files

Seq Description Document Type Size
1 DEF 14A sbph-def14a_20170615.htm DEF 14A 744288
2 GRAPHIC g201704281648292482049.jpg GRAPHIC 80719
3 GRAPHIC g201704281648292162048.jpg GRAPHIC 67036
4 GRAPHIC g201704281648222442047.jpg GRAPHIC 5838
  Complete submission text file 0001564590-17-007755.txt   957266
Mailing Address 86 SOUTH STREET HOPKINTON MA 01748
Business Address 86 SOUTH STREET HOPKINTON MA 01748 508-473-5993 X119
Spring Bank Pharmaceuticals, Inc. (Filer) CIK: 0001566373 (see all company filings)

IRS No.: 522386345 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-37718 | Film No.: 17795303
SIC: 2834 Pharmaceutical Preparations